Search

Search Constraints

You searched for: Author/Creator Mindos, Thomas

Search Results

3. Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2–associated schwannomas reveals differences in efficacy and drug resistance development. Issue 4 (6th January 2019)